Journal articles on the topic 'Benralizumab'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Benralizumab.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Pini, Laura, Diego Bagnasco, Bianca Beghè, et al. "Unlocking the Long-Term Effectiveness of Benralizumab in Severe Eosinophilic Asthma: A Three-Year Real-Life Study." Journal of Clinical Medicine 13, no. 10 (2024): 3013. http://dx.doi.org/10.3390/jcm13103013.
Full textMalakauskas, Kęstutis, Kristina Biekšienė, Marius Zolubas, et al. "Benralizumabo veiksmingumas gydant sunkia eozinofiline astma sergančius pacientus. BREEZE tyrimo Lietuvos duomenys." Pulmonology and allergology 8, no. 2 (2024): 175–80. http://dx.doi.org/10.37499/pia.1486.
Full textMiguel Reyes, José Luis, Erika del Carmen López Estrada, Monserrat Arroyo Rojas, et al. "Benralizumab in severe eosinophilic asthma: A real-world, single-center, observational study from Mexico." Allergologia et Immunopathologia 51, no. 6 (2023): 8–15. http://dx.doi.org/10.15586/aei.v51i6.852.
Full textAntoniu, S. A. "Benralizumab." Drugs of the Future 39, no. 7 (2014): 463. http://dx.doi.org/10.1358/dof.2014.039.07.2156125.
Full textAntoniu, S. A. "Benralizumab." Drugs of the Future 39, no. 7 (2014): 463. http://dx.doi.org/10.1358/dof.2014.39.7.2156125.
Full textSandhu, Yuuki, Norihiro Harada, Hitoshi Sasano, et al. "Pretreatment Frequency of Circulating Th17 Cells and FeNO Levels Predicted the Real-World Response after 1 Year of Benralizumab Treatment in Patients with Severe Asthma." Biomolecules 13, no. 3 (2023): 538. http://dx.doi.org/10.3390/biom13030538.
Full textZhuravleva, M. V., S. N. Avdeev, Yu V. Gagarina, and T. V. Marin. "Pharmacoeconomic analysis of using benralizumab for treatment of severe asthma in inpatient and outpatient settings." FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology 15, no. 2 (2022): 175–86. http://dx.doi.org/10.17749/2070-4909/farmakoekonomika.2022.143.
Full textShnaider, К. О., M. L. Maksimov, and S. А. Martynova. "Efficacy and safety of benralizumab." Glavvrač (Chief Medical Officer), no. 10 (October 12, 2024): 31–46. http://dx.doi.org/10.33920/med-03-2410-03.
Full textBourdin, Arnaud, Don Husereau, Nicolas Molinari, et al. "Matching-adjusted indirect comparison of benralizumab versus interleukin-5 inhibitors for the treatment of severe asthma: a systematic review." European Respiratory Journal 52, no. 5 (2018): 1801393. http://dx.doi.org/10.1183/13993003.01393-2018.
Full textMenzella, Francesco, Mariarita Marchi, Marco Caminati, et al. "Long-Term Eosinophil Depletion: A Real-World Perspective on the Safety and Durability of Benralizumab Treatment in Severe Eosinophilic Asthma." Journal of Clinical Medicine 14, no. 1 (2024): 191. https://doi.org/10.3390/jcm14010191.
Full textScioscia, Giulia, Pasquale Tondo, Santi Nolasco, et al. "Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life Experience." Journal of Clinical Medicine 12, no. 13 (2023): 4362. http://dx.doi.org/10.3390/jcm12134362.
Full textNaumova, V. V., E. К. Beltyukov, K. A. Zykov та ін. "Effectiveness of anti-IL-5Rα-therapy in patients with T2-inflammatory airway diseases in real clinical practice". Meditsinskiy sovet = Medical Council, № 20 (11 грудня 2024): 40–50. https://doi.org/10.21518/ms2024-499.
Full textSakai, Natsumi, Toshiyuki Koya, Yui Murai, et al. "Effect of Benralizumab on Mucus Plugs in Severe Eosinophilic Asthma." International Archives of Allergy and Immunology 184, no. 8 (2023): 783–91. http://dx.doi.org/10.1159/000530392.
Full textAndo, Koichi, Akihiko Tanaka, and Hironori Sagara. "Comparative Efficacy and Safety of Dupilumab and Benralizumab in Patients with Inadequately Controlled Asthma: A Systematic Review." International Journal of Molecular Sciences 21, no. 3 (2020): 889. http://dx.doi.org/10.3390/ijms21030889.
Full textBleecker, Eugene R., Michael E. Wechsler, J. Mark FitzGerald, et al. "Baseline patient factors impact on the clinical efficacy of benralizumab for severe asthma." European Respiratory Journal 52, no. 4 (2018): 1800936. http://dx.doi.org/10.1183/13993003.00936-2018.
Full textAlmulhim, Rayanah Nouraldeen, Abdullah Hamad Alsabhawi, Amnah Ali Alkhawajah, et al. "Efficacy of Benralizumab in Paediatric and Adult Populations with Chronic Rhinosinusitis with Nasal Polyps: A Systematic Review and Meta-analysis." Journal of Advanced Trends in Medical Research 1, no. 2 (2024): 409–15. https://doi.org/10.4103/atmr.atmr_155_24.
Full textYamada, Hideyasu, Masayuki Nakajima, Masashi Matsuyama, et al. "Identification of distinct phenotypes related to benralizumab responsiveness in patients with severe eosinophilic asthma." PLOS ONE 16, no. 3 (2021): e0248305. http://dx.doi.org/10.1371/journal.pone.0248305.
Full textTitova, Olga N., Natalia A. Kuzubova, Daria B. Sklyarova, and Maria A. Petrova. "The effectiveness of benralizumab in the treatment of the eosinophilic phenotype of severe asthma in real clinical practice." PULMONOLOGIYA 31, no. 5 (2021): 628–34. http://dx.doi.org/10.18093/0869-0189-2021-31-5-628-634.
Full textFomina, D. S., G. L. Ignatova, T. G. Kabanova, et al. "Efficacy of benralizumab in severe eosinophilic asthma: an interim analysis of a real clinical practice prospective study BEST in Russia." PULMONOLOGIYA 33, no. 3 (2023): 374–85. http://dx.doi.org/10.18093/0869-0189-2023-33-3-374-385.
Full textTsurumaki, Matsuyama, Ezawa, et al. "Rapid Effect of Benralizumab for Hypereosinophilia in a Case of Severe Asthma with Eosinophilic Chronic Rhinosinusitis." Medicina 55, no. 7 (2019): 336. http://dx.doi.org/10.3390/medicina55070336.
Full textNedogoda, Sergey Vladimirovich, Alla Sergeevna Salasyuk, Irina Nikolaevna Barykina, Victoria Olegovna Smirnova та Maksim Yurevich Frolov. "Сost of the Biologacal Therapy for Severe Brochcial Asthma Treatment at Inpatient and Day Care Setting". Medical Technologies. Assessment and Choice (Медицинские технологии. Оценка и выбор), № 1 (39) (1 травня 2020): 61–69. http://dx.doi.org/10.31556/2219-0678.2020.39.1.061-069.
Full textChan, Rory, and Brian J. Lipworth. "Real-life effects of benralizumab on airway oscillometry in severe eosinophilic asthma." BMJ Open Respiratory Research 10, no. 1 (2023): e001472. http://dx.doi.org/10.1136/bmjresp-2022-001472.
Full textTalwar, Deepak, Manoj Yadav, Nagarjuna Maturu, Rahul Sharma, Priti Meshram, and Soumya Das. "An early Indian experience with benralizumab - A compendium on severe asthma cases: a case series." F1000Research 12 (September 27, 2023): 1225. http://dx.doi.org/10.12688/f1000research.132704.1.
Full textDr., M. Govardhan* Shaik Rizwana Alefiya Kotawala. "A Comprehensive Review on Drug Profile of Benralizumab." International Journal of Pharmaceutical Sciences 3, no. 3 (2025): 783–88. https://doi.org/10.5281/zenodo.15000067.
Full textАхмедханов, Seypula Sh, Saida G. Gadzhiyeva, Albina T. Beybalayeva, and Zaira M. Saidova. "Clinical case of benralizumab use in severe eosinophilic bronchial asthma in the Republic of Dagestan." Russian Family Doctor 27, no. 4 (2024): 51–58. http://dx.doi.org/10.17816/rfd569352.
Full textDagher, Rania, Varsha Kumar, Alan M. Copenhaver, et al. "Novel mechanisms of action contributing to Benralizumab's potent anti-eosinophilic activity." European Respiratory Journal, July 21, 2021, 2004306. http://dx.doi.org/10.1183/13993003.04306-2020.
Full text"Benralizumab." Reactions Weekly 1914, no. 1 (2022): 126. http://dx.doi.org/10.1007/s40278-022-18712-0.
Full text"Benralizumab." Reactions Weekly 1895, no. 1 (2022): 95. http://dx.doi.org/10.1007/s40278-022-10520-1.
Full text"Benralizumab." Reactions Weekly 1898, no. 1 (2022): 115. http://dx.doi.org/10.1007/s40278-022-11708-9.
Full text"Benralizumab." Reactions Weekly 1883, no. 1 (2021): 82. http://dx.doi.org/10.1007/s40278-021-06037-1.
Full text"Benralizumab." Reactions Weekly 1891, no. 1 (2022): 72. http://dx.doi.org/10.1007/s40278-022-09324-8.
Full text"Benralizumab." Reactions Weekly 1926, no. 1 (2022): 130. http://dx.doi.org/10.1007/s40278-022-24408-2.
Full text"Benralizumab." Reactions Weekly 2034, no. 1 (2024): 72. http://dx.doi.org/10.1007/s40278-024-70445-6.
Full text"Benralizumab." Reactions Weekly 2037, no. 1 (2024): 87. https://doi.org/10.1007/s40278-024-71780-6.
Full text"Benralizumab." Reactions Weekly 2024, no. 1 (2024): 88. http://dx.doi.org/10.1007/s40278-024-66070-x.
Full text"Benralizumab." Reactions Weekly 2024, no. 1 (2024): 87. http://dx.doi.org/10.1007/s40278-024-66069-y.
Full text"Benralizumab." Reactions Weekly 2033, no. 1 (2024): 58. http://dx.doi.org/10.1007/s40278-024-70168-x.
Full text"Benralizumab." Reactions Weekly 2014, no. 1 (2024): 121. http://dx.doi.org/10.1007/s40278-024-61549-5.
Full text"Benralizumab." Reactions Weekly 2014, no. 1 (2024): 120. http://dx.doi.org/10.1007/s40278-024-61548-5.
Full text"Benralizumab." Reactions Weekly 2014, no. 1 (2024): 122. http://dx.doi.org/10.1007/s40278-024-61550-4.
Full text"Benralizumab." Reactions Weekly 1829, no. 1 (2020): 100. http://dx.doi.org/10.1007/s40278-020-85690-y.
Full text"Benralizumab." Reactions Weekly 1829, no. 1 (2020): 101. http://dx.doi.org/10.1007/s40278-020-85691-y.
Full text"Benralizumab." Reactions Weekly 1831, no. 1 (2020): 81. http://dx.doi.org/10.1007/s40278-020-86337-7.
Full text"Benralizumab." Reactions Weekly 1835, no. 1 (2020): 69. http://dx.doi.org/10.1007/s40278-020-87513-2.
Full text"Benralizumab." Reactions Weekly 1818, no. 1 (2020): 57. http://dx.doi.org/10.1007/s40278-020-82337-6.
Full text"Benralizumab." Reactions Weekly 1933, no. 1 (2022): 116. http://dx.doi.org/10.1007/s40278-022-28067-5.
Full text"Benralizumab." Reactions Weekly 1747, no. 1 (2019): 62. http://dx.doi.org/10.1007/s40278-019-59703-5.
Full text"Benralizumab." Reactions Weekly 1957, no. 1 (2023): 92. http://dx.doi.org/10.1007/s40278-023-39217-7.
Full text"Benralizumab." Reactions Weekly 1955, no. 1 (2023): 101. http://dx.doi.org/10.1007/s40278-023-38348-5.
Full text"Benralizumab." Reactions Weekly 2042, no. 1 (2025): 80. https://doi.org/10.1007/s40278-025-74879-4.
Full text